Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07071415 · ClinicalTrials.gov registry record · NA
Overdiagnosis and Breast Cancer Screening Decisions
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 311
- Enrollment target
NCT07071415 is a NA study that has completed, run by Yale University. The registered enrollment target is 311 participants.
The verdict
NCT07071415, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 311 participants
- Enrollment target
Study Summary
This is a survey-based study using an online panel. The goal of the study is to understand whether information about overdiagnosis influences breast cancer screening intention among older women. Participants are first asked a series of questions about breast cancer screening including their intention to continue screening, knowledge of screening, and beliefs about screening. They are then shown one of three videos about breast cancer screening that contain information about overdiagnosis or a fourth control video that is identical but contains no information about overdiagnosis. Participants are then again asked about screening intention, along with knowledge of screening, overdiagnosis, and questions around trust.
Interventions
- OTHER Control condition
- BEHAVIORAL Breast cancer screening decision aid -- low risk
- BEHAVIORAL Breast cancer decision aid -- moderate risk
- BEHAVIORAL Breast cancer screening decision aid -- high risk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 311 participants |
| Start Date | 2025-08-19 |
| Est. Completion | 2025-10-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07071415
The ClinicalTrials.gov registry entry for NCT07071415 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 311 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Control condition is the first listed.
NCT07071415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07071415 about?
NCT07071415 is a clinical study titled "Overdiagnosis and Breast Cancer Screening Decisions". This is a survey-based study using an online panel. The goal of the study is to understand whether information about overdiagnosis influences breast cancer screening intention among older women. Participants are first asked a series of questions about breast cancer screening including their intentio...
What is the current status of trial NCT07071415?
This trial is currently completed. It is a NA study. The enrollment target is 311 participants. The study started on 2025-08-19. Estimated completion is 2025-10-20.
What interventions are being tested in trial NCT07071415?
The interventions under investigation include: Control condition (OTHER), Breast cancer screening decision aid -- low risk (BEHAVIORAL), Breast cancer decision aid -- moderate risk (BEHAVIORAL), Breast cancer screening decision aid -- high risk (BEHAVIORAL).
Who is sponsoring clinical trial NCT07071415?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.